Table 2.
Objective questionnaire scores described in means out of 100
| Consent component | Consent type | |
|---|---|---|
| Verbal assent | Written consent | |
| Purpose of consent | 91.67 | 100.00 |
| Purpose of study | 41.67 | 66.67 |
| Duration of study | 45.83 | 25.00 |
| Nature of study intervention | 50.00 | 66.67 |
| Number of study groups | 50.00 | 75.00 |
| Understanding of alternative treatments | 33.33 | 33.33 |
| Randomization | 37.50 | 50.00 |
| Blindness | 25.00 | 25.00 |
| Side effects | 70.83 | 33.33 |
| Contacts in case of side effects | 62.50 | 25.00 |
| Compensation in case of harm | 58.33 | 75.00 |
| Voluntariness of withdraw | 83.33 | 91.67 |
| Treatment options if refused to participate | 75.00 | 83.33 |
| Benefits of participation | 70.00 | 100.00 |
| Financial benefits of participation | 83.33 | 91.67 |
| Confidentiality | 83.33 | 83.33 |
| Whom to contact for any complaints | 83.33 | 75.00 |
| Total Score | 61.47 | 64.71 |